-
Mashup Score: 0JUVE-BASIS: Support for baricitinib in juvenile arthritis - 1 year(s) ago
The Janus kinase inhibitor baricitinib has the potential to be “an important part of the treatment landscape” for juvenile arthritis, research suggests.
Source: rheumatology.medicinematters.comCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 1Secukinumab comparable to adalimumab biosimilar in axSpA - 1 year(s) ago
Researchers have found that secukinumab performs equally well to adalimumab biosimilar for the treatment of radiographic axial spondyloarthritis in a head-to-head trial.
Source: rheumatology.medicinematters.comCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 1COVID-19 vaccination advocated for pregnant women with RMDs - 2 year(s) ago
COVID-19 vaccination should be actively promoted for women with rheumatic and musculoskeletal diseases who are pregnant or planning a pregnancy, say researchers.
Source: rheumatology.medicinematters.comCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 1Phase 3 trial supports add-on telitacicept for SLE - 2 year(s) ago
Addition of the recombinant fusion protein telitacicept to standard care may reduce disease activity and is well tolerated in people with systemic lupus erythematosus, research suggests.
Source: rheumatology.medicinematters.comCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 1
Early trial results suggest that ultrasound-guided genicular nerve block may represent a promising short-term treatment option for pain associated with knee osteoarthritis.
Source: rheumatology.medicinematters.comCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 5FDA authorizes anakinra for severe COVID-19 - 2 year(s) ago
Click through for further information
Source: rheumatology.medicinematters.comCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 1Achieving LLDAS tied to reduced mortality risk in SLE - 2 year(s) ago
Achievement of LLDAS is associated with a significant reduction in mortality risk among people with systemic lupus erythematosus, study findings suggest.
Source: rheumatology.medicinematters.comCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0Pre-eclampsia warning for women with PsA or RA - 2 year(s) ago
The risk for pre-eclampsia is increased in pregnant women with psoriatic arthritis or severe rheumatoid arthritis, but not those with axial spondyloarthritis, suggests research published in RMD Open.
Source: rheumatology.medicinematters.comCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 2ASAS, EULAR issue updated recommendations on axSpA management - 2 year(s) ago
The Assessment of SpondyloArthritis international Society and EULAR have issued up-to-date guidance on the management of radiographic and nonradiographic axial spondyloarthritis.
Source: rheumatology.medicinematters.comCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 1Dapagliflozin may warrant further investigation for SLE - 2 year(s) ago
Dapagliflozin deserves further study as an add-on therapy for reducing renal and cardiovascular risk in patients with systemic lupus erythematosus, suggest preliminary trial findings.
Source: rheumatology.medicinematters.comCategories: Latest Headlines, RheumatologyTweet
#ACR22 news: Baricitinib has the potential to be “an important part of the treatment landscape” for juvenile arthritis, suggest findings from the JUVE-BASIS trial reported by Athimalaipet Ramanan (@uhbwNHS) https://t.co/lWmwh7qHSY